Skip to main content
. 2021 Apr 19;12:650967. doi: 10.3389/fendo.2021.650967

Table 1.

BIPSS results in pediatric population with Cushing disease.

Patient Pre-oCRH C/P ratio Post-oCRH stimulation C/P ratio Tumor location Treatment outcome Histopathological confirmation a
MRI BIPSS basal/CRH stimulation Surgery
1 21.5 63.2 normal R R no relapse microadenoma
2 9.3 23.3 normal L C no relapse microadenoma
3 0.8 1.1 heterogenous  lateralization
(-)
C no relapse microadenoma
4 1.5 1.4 normal lateralization
(-)
L no relapse microadenoma
5 3.7 19.5 3mm (L)  L no relapse microadenoma
6 14.9 27.0 heterogenous R R no relapse microadenoma
7 8.3 22.4 4mm (R) R R 2 x surgery
RTX
bilateral adrenalectomy
1.microadenoma
2.microadenoma
8 1.3 5.6 normal R C 2 x surgery 1.microadenoma
2.microadenoma
9 94.5 750.2 normal  L no relapse corticotropin cell hyperplasia, IHC ACTH (+)
10 43.4 115 heterogenous R R no relapse pituitary
11 15.8 20.3 heterogenous R R no relapse microadenoma, IHC ACTH (-)
12 30.7 303.4 normal L L 2 x surgery 1.microadenoma, IHC ACTH (+)
2.microadenoma

R, right; L, left; IHC, immunohistochemistry.

a

IHC staining for ACTH was performed since 2016.